Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways

被引:16
作者
Martinez-Revollar, Gabriela [1 ]
Garay, Erika [2 ]
Martin-Tapia, Dolores [1 ]
Nava, Porfirio [1 ]
Huerta, Miriam [3 ]
Lopez-Bayghen, Esther [4 ]
Meraz-Cruz, Noemi [5 ,6 ]
Segovia, Jose [1 ]
Gonzalez-Mariscal, Lorenza [1 ]
机构
[1] Ctr Res & Adv Studies CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico
[2] Ctr Res & Adv Studies CINVESTAV, Natl Labs Genom Biodivers, Irapuato, Mexico
[3] Inst Tecnol Monterrey ITESM, Dept Biotechnol, Puebla, Mexico
[4] Ctr Res & Adv Studies CINVESTAV, Dept Toxicol, Mexico City, DF, Mexico
[5] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico
[6] Natl Inst Genom Med, Mexico City, DF, Mexico
关键词
Triple negative breast cancer; beta-catenin; AKT; Wnt; Cancer cells heterogeneity; BASAL-LIKE SUBTYPE; TIGHT JUNCTIONS; GENE-EXPRESSION; POOR-PROGNOSIS; BETA-CATENIN; SNAIL; TRANSCRIPTION; INHIBITOR; TYROSINE; LINES;
D O I
10.1016/j.yexcr.2015.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The lack of a successful treatment for triple-negative breast cancer demands the study of the heterogeneity of cells that constitute these tumors. With this aim, two clones from triple negative breast MDA-MB-231 cancer cells were isolated: One with fibroblast-like appearance (F) and another with semi-epithelial (SE) morphology. Cells of the F clone have a higher migration and tumorigenesis capacity than SE cells, suggesting that these cells are in a more advanced stage of epithelial to mesenchymal transformation. In agreement, F cells have a diminished expression of the tight junction proteins claudins 1 and 4, and an increased content of P-catenin. The latter is due to an augmented activity of the canonical Wnt route and of the EGFR/PI3K/mTORC2/AKT pathway favoring the cytoplasmic accumulation of beta-catenin and its transcriptional activity. In addition, F cells display increased phosphorylation of beta-catenin at Tyr654 by Src. These changes favor in F cells, the over-expression of Snail that promotes EMT. Finally, we observe that both F and SE cells display markers of cancer stem cells, which are more abundant in the F clone. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:67 / 80
页数:14
相关论文
共 54 条
  • [1] Neurotensin Receptor 1 Determines the Outcome of Non-Small Cell Lung Cancer
    Alifano, Marco
    Souaze, Frederique
    Dupouy, Sandra
    Camilleri-Broet, Sophie
    Younes, Mohamad
    Ahmed-Zaid, Sadi-Menad
    Takahashi, Takashi
    Cancellieri, Alessandra
    Damiani, Stefania
    Boaron, Maurizio
    Broet, Philippe
    Miller, Lance D.
    Gespach, Christian
    Regnard, Jean Francois
    Forgez, Patricia
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (17) : 4401 - 4410
  • [2] Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
    Bafico, A
    Liu, GZ
    Yaniv, A
    Gazit, A
    Aaronson, SA
    [J]. NATURE CELL BIOLOGY, 2001, 3 (07) : 683 - 686
  • [3] The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
    Batlle, E
    Sancho, E
    Franci, C
    Domínguez, D
    Monfar, M
    Baulida, J
    de Herreros, AG
    [J]. NATURE CELL BIOLOGY, 2000, 2 (02) : 84 - 89
  • [4] Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype
    Blanchard, Anne A.
    Skliris, George P.
    Watson, Peter H.
    Murphy, Leigh C.
    Penner, Carla
    Tomes, Ladislav
    Young, Tamara L.
    Leygue, Etienne
    Myal, Yvonne
    [J]. VIRCHOWS ARCHIV, 2009, 454 (06) : 647 - 656
  • [5] TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
    Carey, Lisa A.
    Rugo, Hope S.
    Marcom, P. Kelly
    Mayer, Erica L.
    Esteva, Francisco J.
    Ma, Cynthia X.
    Liu, Minetta C.
    Storniolo, Anna Maria
    Rimawi, Mothaffar F.
    Forero-Torres, Andres
    Wolff, Antonio C.
    Hobday, Timothy J.
    Ivanova, Anastasia
    Chiu, Wing-Keung
    Ferraro, Madlyn
    Burrows, Emily
    Bernard, Philip S.
    Hoadley, Katherine A.
    Perou, Charles M.
    Winer, Eric P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2615 - 2623
  • [6] Triple-negative breast cancer: therapeutic options
    Cleator, Susan
    Heller, Wolfgang
    Coombes, R. Charles
    [J]. LANCET ONCOLOGY, 2007, 8 (03) : 235 - 244
  • [7] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B
    CROSS, DAE
    ALESSI, DR
    COHEN, P
    ANDJELKOVICH, M
    HEMMINGS, BA
    [J]. NATURE, 1995, 378 (6559) : 785 - 789
  • [8] Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
    Debnath, J
    Muthuswamy, SK
    Brugge, JS
    [J]. METHODS, 2003, 30 (03) : 256 - 268
  • [9] Triple-negative breast cancer: Clinical features and patterns of recurrence
    Dent, Rebecca
    Trudeau, Maureen
    Pritchard, Kathleen I.
    Hanna, Wedad M.
    Kahn, Harriet K.
    Sawka, Carol A.
    Lickley, Lavina A.
    Rawlinson, Ellen
    Sun, Ping
    Narod, Steven A.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4429 - 4434
  • [10] Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling
    Ding, VW
    Chen, RH
    McCormick, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) : 32475 - 32481